Rhumbline Advisers Immunity Bio, Inc. Transaction History

Rhumbline Advisers

  • $121 Billion
  • Q3 2025

A detailed history of Rhumbline Advisers transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 314,623 shares of IBRX stock, worth $654,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314,623
Previous 334,557 5.96%
Holding current value
$654,415
Previous $883,000 12.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
SELL
$2.24 - $3.01 $44,652 - $60,001
-19,934 Reduced 5.96%
314,623 $773,000
Q2 2025

Aug 12, 2025
BUY
$1.89 - $3.44 $217,722 - $396,277
115,197 Added 52.52%
334,557 $883,000
Q1 2025

Apr 08, 2025
BUY
$2.32 - $3.9 $26,849 - $45,134
11,573 Added 5.57%
219,360 $688,000
Q4 2024

May 29, 2025
SELL
$2.56 - $6.17 $29,626 - $71,405
-11,573 Reduced 5.28%
207,787 $531,000
Q4 2024

Jan 30, 2025
BUY
$2.56 - $6.17 $765 - $1,844
299 Added 0.14%
207,787 $531,000
Q3 2024

Nov 12, 2024
SELL
$3.32 - $6.7 $13,907 - $28,066
-4,189 Reduced 1.98%
207,488 $769,000
Q2 2024

Aug 01, 2024
BUY
$4.82 - $9.15 $119,545 - $226,938
24,802 Added 13.27%
211,677 $1.34 Million
Q1 2024

May 09, 2024
BUY
$3.23 - $6.17 $25,953 - $49,575
8,035 Added 4.49%
186,875 $1 Million
Q4 2023

Feb 08, 2024
BUY
$1.25 - $5.21 $46,306 - $193,004
37,045 Added 26.13%
178,840 $897,000
Q3 2023

Nov 09, 2023
SELL
$1.29 - $3.1 $6,901 - $16,585
-5,350 Reduced 3.64%
141,795 $239,000
Q2 2023

Aug 08, 2023
BUY
$1.53 - $6.41 $54,117 - $226,728
35,371 Added 31.65%
147,145 $409,000
Q1 2023

May 11, 2023
SELL
$1.35 - $4.78 $1,120 - $3,967
-830 Reduced 0.74%
111,774 $203,000
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.77 $13,384 - $20,831
3,077 Added 2.81%
112,604 $571,000
Q3 2022

Nov 10, 2022
BUY
$3.65 - $6.43 $31,006 - $54,622
8,495 Added 8.41%
109,527 $544,000
Q2 2022

Aug 11, 2022
BUY
$2.68 - $6.14 $34,596 - $79,261
12,909 Added 14.65%
101,032 $376,000
Q1 2022

May 12, 2022
SELL
$5.05 - $7.53 $10,882 - $16,227
-2,155 Reduced 2.39%
88,123 $494,000
Q4 2021

Feb 10, 2022
SELL
$5.67 - $10.18 $12,077 - $21,683
-2,130 Reduced 2.3%
90,278 $549,000
Q3 2021

Nov 12, 2021
BUY
$9.17 - $14.24 $29,967 - $46,536
3,268 Added 3.67%
92,408 $900,000
Q2 2021

Aug 05, 2021
BUY
$13.41 - $22.4 $687,249 - $1.15 Million
51,249 Added 135.25%
89,140 $1.27 Million
Q1 2021

May 06, 2021
BUY
$12.83 - $42.25 $486,141 - $1.6 Million
37,891 New
37,891 $900,000

Others Institutions Holding IBRX

# of Institutions
298
Shares Held
137M
Call Options Held
2.59M
Put Options Held
3.35M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $833M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email